Reckitt Benckiser Group will pay up to $1.4 billion to settle U.S. investigations into whether its former pharma unit organized a multibillion-dollar fraud to drive up sales of its opioid-addiction treatment, Suboxone. (Source: PharmaManufacturing.com)

{ 0 comments }

A divided federal appeals court on Friday ruled against Indivior Plc in its bid to stop Dr. Reddy’s Laboratories Ltd and Alvogen from selling generic versions of its opioid addiction treatment Suboxone film that infringed its patents. (Source: Reuters: Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

{ 0 comments }

Indivior raises guidance on strong performance of opioid treatment

July 12, 2019

Suboxone drug has been at the centre of a US probe into its marketing (Source: FT.com – Drugs and Healthcare) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

New Jersey Authorizes Paramedics to Carry Buprenorphine

July 4, 2019

TRENTON (Cape May County Herald) – The State Health Commissioner June 24 authorized paramedics to carry buprenorphine to treat acute withdrawal symptoms after patients have been revived from an opioid overdose with Naloxone, the opioid overdose reversal drug. According to a release, Commissioner Dr. Shereef Elnahal signed an Executive Directive on that date allowing the […]

Read the full article →

Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids – Barocas JA, Morgan JR, Fiellin DA, Schackman BR, Eftekhari Yazdi G, Stein MD, Freedberg KA, Linas BP.

May 18, 2019

BACKGROUND: Untreated opioid use disorder (OUD) affects the care of HIV/HCV co-infected people who inject opioids. Despite active injection opioid use, there is evidence of increasing engagement in HIV care and adherence to HIV medications among HIV/HCV co… (Source: SafetyLit) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log […]

Read the full article →

U.S. indicts Indivior over Suboxone opioid treatment marketing

April 11, 2019

The U.S. Justice Department announced on Tuesday the indictment of Indivior Plc and a subsidiary on charges they engaged in an illegal scheme to boost prescriptions of the film version of its opioid addiction treatment Suboxone. (Source: Reuters: Health)

Read the full article →

Indivior shares tank after U.S. indictment for illegal marketing

April 11, 2019

Shares of Indivior Plc sank 44 percent on Wednesday after the U.S. Justice Department accused the British drugmaker of illegally boosting prescriptions for the film version of its blockbuster opioid addiction treatment Suboxone. (Source: Reuters: Health)

Read the full article →

Anti-opioid addiction drug maker charged with fraud

April 11, 2019

Federal prosecutors in Virginia say the company that makes a Suboxone strips to curb opioid addiction has been lying for years about the relative safety of its product (Source: ABC News: Health)

Read the full article →

DOJ charges UK drugmaker with Suboxone fraud

April 11, 2019

Federal prosecutors with the Department of Justice have indicted Indivior for what they call a multibillion-dollar scheme to ratchet up sales of an opioid addiction treatment. (Source: PharmaManufacturing.com)

Read the full article →

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

April 11, 2019

British drugmaker Indivior Plc lost nearly three-quarters of its share value on Wednesday and former parent Reckitt Benckiser also fell following U.S. criminal charges accusing Indivior of illegally increasing prescriptions for its opioid addiction treatment Suboxone. (Source: Reuters: Health) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on […]

Read the full article →